ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

2024 Updates in Ovarian Cancer

Total Health

T. Tillmanns

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

Defining Platinum Resistance in Ovarian Cancer

Michael Birrer

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

Precision Oncology in the Management of Ovarian Cancer

Miami Cancer Institute Precision Oncology Symposium

D. Dizon

Overview of Ovarian Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

Year in Review: Ovarian Cancer

Fengting Yan

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Yale School of Medicine

M. Minkin, E. Ratner

UChicago Medicine Best of ASCO® 2024: Options for Recurrent Platinum…

UChicago Medicine Annual Practice Updates in Hematology and Oncology

H. Cun

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer"

Insights from 2024 ESGO Annual Meeting

J. Kurtz

Recent Highlights in Ovarian Cancer

Total Health

B. Slomovitz

Treatment Options for Platinum-Sensitive Recurrent Ovarian Cancer

Richard Penson

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective Gluco…

Insights from 2024 SGO Annual Meeting

N. Colombo

Addressing the Critical Gaps in Relapsed Ovarian Cancer Management

Michael Birrer

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Ovarian Cancer Midwest Focus, University of Minnesota

S. Lheureux

SGO 2024 Insights: "COMB1NE Study - Characteristics and Real-World O…

Insights from 2024 SGO Annual Meeting

P. Thaker

Ovarian Cancer: Setting a New Standard of Care

OncoAlert

M. Raza Mirza